Cemtrex, Inc. — Form 10-Q Summary
Reporting period: The filing covers the three months ended December 31, 2022, Cemtrex’s first quarter of fiscal 2023. The financial statements are unaudited. The company operates Security (Vicon), Industrial Services (AIS), and Corporate segments.
Financial performance and liquidity
- Revenue: $11.97 million, up 27% from $9.41 million a year earlier. Security revenue rose 40% to $7.00 million; Industrial Services revenue declined 2% to $4.97 million.
- Profitability: Gross profit was $5.04 million, or 42% of revenue, versus $3.22 million, or 34%, a year earlier. Operating loss narrowed to $1.95 million from $3.30 million. Continuing-operations loss was $3.10 million, compared with $3.77 million.
- Net loss: $6.34 million, versus $4.53 million. The loss attributable to Cemtrex shareholders was $6.28 million; discontinued operations and the sale of businesses were the principal factors behind the higher total loss. Interest expense was $1.13 million.
- Cash flow: Continuing operations used $5.87 million in operating cash. Discontinued operations provided $2.50 million, leaving total operating cash use of $3.37 million. Investing activities used $0.36 million overall and financing activities used $0.60 million. Cash, cash equivalents, and restricted cash declined $4.33 million to $7.37 million.
- Liquidity: Cash and equivalents were $5.77 million; restricted cash was $1.60 million and is held for employee medical-plan obligations. Working capital was a deficit of $0.47 million, versus a $4.75 million surplus at September 30, 2022.
- Debt: Notes payable totaled $20.30 million, including $17.10 million classified as current. Major maturities include notes due in March and August 2023. Total liabilities were $32.11 million; total assets were $40.91 million.
Changes and unusual items
- Management attributed the revenue increase primarily to higher demand. Security gross margin improved to 49% from 41%, reflecting price increases; Industrial Services gross margin rose to 33% from 28%, primarily due to lower subcontractor costs. Research and development expense increased to $1.54 million from $1.07 million.
- On November 22, 2022, Cemtrex sold Cemtrex XR and Cemtrex Advanced Technologies, including SmartDesk and other brands, to CEO Saagar Govil. The filing reports a loss on sale of approximately $2.46 million. Consideration included cash, royalty arrangements, and a SAFE; the company valued the SmartDesk royalty and SAFE at zero, while recognizing a discounted royalty receivable for Cemtrex XR.
- The company reorganized its reportable segments. It also completed a 35-for-1 common-stock reverse split on January 25, 2023. Common shares were issued during the quarter to satisfy debt and accrued interest.
- Management cited higher receivables and prepaid expenses, among other factors, as drivers of cash use. It said inflation had not materially affected the reported periods. No quantified financial guidance was provided.
Outlook, risks, and controls
- Going concern: The filing states that recurring losses, $17.10 million of current debt obligations, and the working-capital deficit raise substantial doubt about the company’s ability to continue as a going concern. Management said cash was inadequate for short- and long-term needs. It expects asset sales, cost and pricing actions, and possible equity financing or debt settlement with shares to help, but cautioned that success and adequate funding are not assured; equity issuance may dilute shareholders.
- Nasdaq: The company reported regaining compliance with the common-stock minimum bid-price rule on February 8, 2023. Nasdaq had separately extended the cure period for the Series 1 Preferred Stock minimum bid-price requirement through July 24, 2023.
- Internal controls: Management concluded disclosure controls were ineffective and identified a material weakness tied to insufficient accounting personnel, period-end review, account reconciliations, and asset-recoverability assessment. It cited upgraded accounting software and a third-party accounting firm as remediation steps, not yet fully evaluated.
- The filing identifies risks including economic and competitive conditions, manufacturing or supplier problems, and access to sufficient credit. It reports no legal proceedings.
Important facts for investors to verify
- Whether Cemtrex can meet or refinance near-term debt maturities and fund operations, given the stated going-concern uncertainty.
- The status and terms of the related-party asset sale, including royalty collections, the SAFE, and the reported sale loss.
- Progress in remediating the material weakness and improving financial reporting controls.
- Nasdaq compliance status for both common and Series 1 Preferred Stock, and the potential effects of further equity issuance or debt-for-equity settlements.
- Several figures differ slightly within the filing, including the loss attributable to shareholders and the discontinued-operations sale loss; investors should consult the financial statements and notes for the reported values.